September 3, 2010dia

thumbnail
Temple, O'Neill At DIA

Global Doubts

July 12, 2010

As the industry scrambles to find the patients it needs outside the U.S., the organizers of the 2010 annual Drug Information Association (DIA) in Washington, D.C. decided to assemble the sort of luminary-packed panel discussions that only the DIA can present. The session on multi-regional trials began with Doug Peddicord, executive director of the Association of Clinical Research Organizations (ACRO), and was followed by two high-level speakers from FDA. Peddicord was able to review a now-familiar litany of data from clinicalrials.gov, the FDA-NIH repository. Peddicord estimated the decline in the numbers of U.S. projects at 5.5 percent annually, Europe’s drop at 6.1 percent. The winners? India, with growth in projects of 45 percent; and Korea, with a 27 percent increase. “If real estate is about location, location, location, clinical research is about numbers, numbers, numbers,” Peddicord said. ACRO is in the process of trying to study whether there is any demonstrably…more...

thumbnail
2010 Keynote Address

Hamburg At DIA Annual

June 17, 2010

The 2010 annual Drug Information Association meeting began with a new dual-element musical interlude. The first composition amounted to elevator music, by an anonymous band inspired by the hard rock of…more...

thumbnail
Searching For Sticky Notes

Auditing Technology At Trial Sites

August 10, 2007

We’re digesting our DIA notes from this year’s annual meeting in Atlanta. Still. One of memorable presentations was from Susan Flynn, chief quality officer at Clinsys Clinical Research, a contract research…more...

thumbnail
Ken Getz At DIA

Tufts Data: Veteran P.I.s Drop Out

July 19, 2007

In countries outside the U.S., principal investigators who elect not to do any more trials are usually the nervous newbies. That’s not a shock. What is surprising is that here in…more...

thumbnail
Who Should Not Recruit?

Clarification: Pfizer Site Strategy

July 11, 2007

After a complaint from Pfizer, we’ve updated a recent story about DIA. There’s a link to our first story at the bottom of this article. It’s clear ClinPage accurately quoted Andy Lee, Pfizer’s vice president of clinical study and data management. He and the company do have concerns about sites working for too many sponsors, using too…more...

thumbnail
Our Revised Story

Pfizer: Dance With Only Me

June 29, 2007

Editor’s note:  This story has been revised since it was posted on June 29, 2007. Contrary to our initial article, Pfizer has never asked any site to choose between working for Pfizer and another sponsor. As it explained at DIA, however, Pfizer is guiding more sites and investigators to either recruit patients for its trials or make…more...

thumbnail
BBK’s Freebie Generates Buzz

DIA Swag of Choice

June 25, 2007

“A major manufacturer is interested in funding your Phase II study. Collect $150.” “Investors are impressed with your Phase I results. Collect $50.” “Discover new reptile saliva extract that offers a potential cancer treatment. Collect $150.” It’s all part of “Monopoly: The Clinical Research and Development Edition,” a creative (and bulky) bit of swag that had folks…more...

No articles available


© 2010 ClinPage. All Rights Reserved.